This scale was developed Dr. Malaz Boustani, a researcher at the Regenstrief Institute and the Indiana University Center for Aging Research, and her colleagues.
A drug was given a score of 1 if it had possible anticholinergic effects based on lab tests but no evidence of clinically relevant cognitive effects A drug was given a score of 2 or 3 if it had established and clinically relevant anticholinergic effects. Drugs not listed have a score of 0.
To continue reading this article, you must log in.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise
I'd like to receive access to Harvard Health Online for only $4.99 a month.Sign Me Up
Already a member? Login ».
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.